Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Madrigal Pharmaceuticals poised for market dominance with Rezdiffra’s first full quarter…
As per the GlobalData report, as Rezdiffra secures its position as a first-line treatment for MASH, Madrigal Pharmaceuticals eyes…
Dr Reddy’s Labs gets US FDA clearance: Visakhapatnam facilities classified as VAI
USFDA concludes inspection of Dr Reddy's Visakhapatnam units with Voluntary Action Indicated status
Indian biotech start-ups: Need for pragmatic, pro-active, progressive regulatory milieu
Dr Arun Bhatt, Consultant – Clinical Research and Drug Development highlights that the Indian biotech startup sector has surged in…
Balancing cost and value with TCO
Total Cost of Ownership (TCO) is a crucial focus in the pharma industry, influencing sustainability and competitiveness.…
AYUSH, PHD Chamber of Commerce and Industry organise conference on labelling and packaging…
There’s a need for a strategic shift in labelling practices, particularly for Ayurvedic medicines said Dr Kousthubha Upadhyay,…
Merck signs an MoU with Aragen
The collaboration aims to facilitate the supply of equipment and technologies for mAb (monoclonal antibody) manufacturing and…
Amgen to open a new site in Hyderabad
The site, known as Amgen India, aims to accelerate digital capabilities across the global organisation to further advance Amgen’s…
Granules India gains ANDA approval for Trazodone tablets
The current annual US market for Trazodone tablets is approximately $128 million, according to MAT Jun 2024, IQVIA/IMS Health
Zydus gains final USFDA approval for Valbenazine Capsules
Valbenazine Capsules had annual sales of $ 1,993.6 million in the United States (IQVIA MAT June 2024)
Panel Discussion: Forging the path for tomorrow’s therapeutics: Opportunities &…
FDD Conclave 2024 | Day 2 | 20th July 2024 | Hyderabad